Prime Medicine Discusses Liver Disease Franchise Strategy with Focus on Wilson Disease

Prime Medicine discusses its liver disease franchise strategy, focusing on Wilson disease. The company aims to leverage its platform to develop Prime Editors that can offer durable cures for patients. CEO Allan Reine will provide an introduction and context, while Dr. Michael Schilsky, a hepatologist, will discuss the global opportunity in Wilson disease. The presentation will also include a Q&A session with the management team and a key opinion leader.